Alzamend neuro announces initiation date of phase ii clinical trial of al001 for treatment of major depressive disorder to take place at massachusetts general hospital

Alzamend neuro announces initiation date of phase ii clinical trial for next-gen lithium treatment of major depressive disorder at mass. general hospital
GM Ratings Summary
GM Quant Ranking